Dr. Leung is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 E Medical Center Dr
Ann Arbor, MI 48109Phone+1 734-936-4000
Summary
- Dr. Denise Leung is a seasoned Neurologist based in Ann Arbor, MI, specializing in Neurooncology. Her education includes her residency, internship, and a fellowship in Neuro-Oncology from Henry Ford Hospital and Wayne State University, along with an MSc from the University of Toronto and a BSc Honors from the University of Western Ontario. Currently, she works in multiple roles at the University of Michigan Medical Center, including Associate Clinical Professor, Division Chief, and Program Director. Her previous experience includes a stint as the Assistant Professor at Oakland University William Beaumont School of Medicine and as Medical Director of Neuro-Oncology at Beaumont Health System. Dr. Leung's expertise lies in treating various neurological conditions like astrocytoma, oligodendroglioma, gliomas, and primary brain tumors. She has several publications to her credit, covering aspects of her specialty, and has contributed to clinical trials in CNS tumor treatment.
Education & Training
- Henry Ford Hospital/Wayne State UniversityFellowship, Neuro-Oncology, 2012 - 2014
- Henry Ford Health/Henry Ford HospitalResidency, Neurology, 2009 - 2012
- Henry Ford Health/Henry Ford HospitalInternship, Transitional Year, 2008 - 2009
- SUNY Upstate Medical UniversityClass of 2008
- University of TorontoMSc
- University of Western OntarioBSc, Honours
Certifications & Licensure
- OH State Medical License 2021 - 2027
- MI State Medical License 2008 - 2025
- American Board of Psychiatry and Neurology Neurology
- United Council for Neurologic SubspecialtiesCertified in Neuro-oncology
Clinical Trials
- Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Roles: Contact
Publications & Presentations
PubMed
- AB036. Targeting glioblastoma de-novo purine metabolism to overcome chemoradiation resistance: an interim result of phase 0/1 clinical trial in newly diagnosed and rec...Yoshie Umemura, Nathan Clarke, Wajd Al-Holou, Ameer Elaimy, Andrew Scott
Chinese Clinical Oncology. 2024-08-01 - 1 citationsPractical guidance for direct oral anticoagulant use in the treatment of venous thromboembolism in primary and metastatic brain tumor patients.Surabhi Ranjan, Denise Leung, Ashley P Ghiaseddin, Jennie W Taylor, Mina Lobbous
Cancer. 2024-05-01 - 4 citationsMetabolomic Profiles of Human Glioma Inform Patient Survival.Andrew J Scott, Luis O Correa, Donna M Edwards, Yilun Sun, Visweswaran Ravikumar
Antioxidants & Redox Signaling. 2023-11-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: